RxDoctor Payments Data

D Gordon Allan, MD

Adult Reconstructive Orthopaedic Surgery · Springfield, ILNPI 1902892607

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,035 of the $6,857 with a category attached, or 73.4%. Zimmer Biomet accounts for 65.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $2,454 and has fallen 87.4% since, to $310 in 2025. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in IL, where the typical reported total is $12,024.

$6,857in general payments, 2019–2025

Across 79 payments — averaging $86.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$4K
  • Stryker$1K
  • Johnson & Johnson$890
  • Ferring Pharmaceuticals Inc.$80
  • Solventum Corporation$17
  • Sanofi-aventis U.S. LLC$15
  • plus $14 from 1 others
$136,127in research payments, 2019–2025

Across 11 payments — averaging $12,375 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$136K

What the payments were for

  • Consulting fees$71310%
  • Travel & lodging$1,10916%
  • Food & beverage$5,03573%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,857 in reported general payments places this provider in the 35th percentile of 67 adult reconstructive orthopaedic surgery providers in Illinois.

See all adult reconstructive orthopaedic surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$347,871
Medicare patients
564
Services billed
3,458

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib236$2,761
Cephalexin240$2,708
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen306$2,178
Doxycycline Hyclate39$912
Dexamethasone267$767
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim77$395
Tramadol Hcl240$390
Clindamycin Hcl22$345
Meloxicam24$40
Methylprednisolone12$37
Ondansetron Hcl12$13

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Springfield

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →